Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Ipca-Citalopram
Active Ingredient:	Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Ipca Pharma (NZ) Pty Limited
Manufacturer:	Ipca Laboratories Limited, Silvassa, India

*Product:*	Keytruda
Active Ingredient:	Pembrolizumab 25mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:	MSD International GmbH (Singapore Branch), Singapore City, Singapore MSD International GmbH t/a MSD Ireland (Carlow), Carlow, Ireland

Dated this 28th day of July 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule